本页面由Tiger Trade Technology Pte. Ltd.提供服务

IDEAYA Biosciences

34.26
-1.8000-4.99%
盘后:34.500.2400+0.70%19:54 EDT
成交量:102.51万
成交额:3,551.55万
市值:32.98亿
市盈率:-17.51
高:36.20
开:36.06
低:34.25
收:36.06
52周最高:42.68
52周最低:26.44
股本:9,627.48万
流通股本:9,437.45万
量比:1.68
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-1.9561
每股收益(LYR):-1.2849
净资产收益率:-16.22%
总资产收益率:-11.54%
市净率:2.75
市盈率(LYR):-26.66

数据加载中...

2021/05/10

重要事件披露

8-K - Current report
2021/04/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/23

重要事件披露

8-K - Current report
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/21

重要事件披露

8-K - Current report
2021/01/19

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2020/12/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/09/24

重要事件披露

8-K - Current report